JP Morgan Maintains Overweight on Sempra, Lowers Price Target to $102

Benzinga Newsdesk www.benzinga.com Negative 90.6%

Neg 90.6% Neu 0% Pos 0%

JP Morgan analyst Aidan Kelly maintains Sempra (NYSE:SRE) with a Overweight and lowers the price target from $113 to $102.